
IndraLab
Statements
Hydroxychloroquine inhibits KCNH2. 30 / 30
|
9
21
eidos
"HCQ is known to block Kv11.1 ( HERG ) and induce prolong QT , thus predisposing the patient to malignant arrhythmia such as torsade de points.70 , 71 However , studies have found that these arrhythmic toxicities are mostly encountered in chronic use with multiple concomitant QT prolonging agents , metabolic abnormalities , renal insufficiency , as well as medication overdose.72 , 73 Because the use of HCQ in COVID-19 has relatively short duration , the risk of developing significant arrhythmia is relatively low ."
reach
"Additionally, for hydroxychloroquine, a recent study pointed out that hydroxychloroquine could lead to unwanted QT interval prolongation by blocking the KCNH2 encoded hERG and Kv11.1 potassium channel, thereby increasing the risk of drug induced torsade de pointes and sudden cardiac death."